|
基于咽–肠–肾轴理论探讨清咽健脾方治疗IgA肾病
|
Abstract:
目的:基于咽–肠–肾轴理论探讨清咽健脾方加减治疗IgA肾病的效果。方法:IgA肾病是临床比较常见的一种原发性肾小球疾病,其主要症状为血尿,伴有不同程度的蛋白尿,高血压、肾病综合征等肾损害。电镜下表现为肾小球体积系膜区免疫复合物IgA的大量沉淀,或以IgA沉淀为主兼见补体C3等沉积。将从中西医两方面角度探讨咽–肠–肾轴理论的可行性及相关治疗方案异同,传统中医学认为,IgA发病责之于肺、脾、肾;西医目前相关主要理论有两点:一是肠肾轴理论,肠道菌群免疫功能在IgA肾病的发生及治疗中起重要作用,二是咽肾密切相关,咽喉为其纽带。本文通过对IgA肾病肠咽肾轴病机的阐释,相关病因阐述以及中西医对于本病的观点及当前治疗方案,并结合本汤药药物作用机制研究,从而进一步探讨清咽健脾方治疗IgA肾病的可行性。结论:基于咽–肠–肾轴理论探讨清咽健脾方治疗IgA肾病的效果良好,能够降低患者24 h尿蛋白定量及尿红细胞计数,有助于改善肾脏功能,延缓肾脏纤维化进展,值得临床采纳。
Objective: To investigate the effect of Qingyan Jianpi decoction on IgA nephropathy based on the theory of pharyngoenteric-instine kidney axis. Methods: IgA nephropathy is a common primary glomerular disease. The main symptoms of IGA nephropathy are hematuria, proteinuria, hypertension, nephrotic syndrome and other renal damage. Under electron microscope, the immunocomplex IgA was deposited in the mesangial area of the glomerular volume, or IgA deposition was mainly accompanied by complement C3 deposition. The feasibility of the pharyngoentero-renal axis theory and the similarities and differences of related treatment schemes will be discussed from the perspectives of traditional Chinese and Western medicine. Traditional Chinese medicine believes that the pathogenesis of IgA is the lung, spleen and kidney. At present, there are two main theories related to Western medicine: Firstly, the enterorenal axis theory which means the immune function of intestinal flora plays an important role in the occurrence and development of IgA nephropathy; secondly, the kidney and throat are connected closely, and the throat is its link. In this paper, through the explanation of the pathogenesis of enteropharyngorenal axis of IgA nephropathy, together with the related etiology, and the views of traditional Chinese and western medicine on this disease and the current treatment plan, we combine these with the study of the mechanism of action of this decoction, to further explore the feasibility of Qingyan Jianpi prescription for the treatment of IgA nephropathy. Conclusion: Based on the theory of pharyng-instine-kidney axis, Qingyan Jianpi formula has a significant effect on IgA nephropathy, which can reduce 24 h urinary protein quantity and urinary red blood cell count, and help to improve renal fibrosis, which is worthy of clinical adoption.
[1] | 于柏松, 刘冰. 原发性IgA肾病的治疗进展[J]. 中国全科医学, 2021, 24(23): 2985-2991. |
[2] | 王淦淦, 郑可, 李雪梅. IgA肾病发病机制的研究进展[J]. 中华肾脏病杂志, 2024, 40(3): 225-230. |
[3] | 田秀娟, 黄晨. IgA肾病免疫炎症发病机制研究进展[J]. 中华肾脏病杂志, 2020, 36(5): 400-405. |
[4] | Barratt, J., Lafayette, R.A., Rovin, B.H. and Fellström, B. (2023) Budesonide Delayed-Release Capsules to Reduce Proteinuria in Adults with Primary Immunoglobulin A Nephropathy. Expert Review of Clinical Immunology, 19, 699-710. https://doi.org/10.1080/1744666X.2023.2206119 |
[5] | 郑桌龙, 林钢, 罗勉那, 等. 成人IgA肾病免疫抑制治疗的研究进展[J]. 医学信息, 2023, 36(14): 183-187. |
[6] | 王晓宇, 张宏志. 24 h尿蛋白定量与IgA肾病病理改变的相关性研究[J]. 中外医学研究, 2015, 13(22): 82-83. |
[7] | 周嘉宝, 高建东. 肠道菌群失调与IgA肾病黏膜免疫机制相关性研究进展[J]. 中国中西医结合肾病杂志, 2020, 21(2): 173-176. |
[8] | 赵娟, 马志刚, 黄文辉, 等. IgA肾病与膜性肾病患者肠道微生物菌群结构分析[J]. 微生物学通报, 2023, 50(2): 632-643. |
[9] | Fabio, S., Claudia, C., Nada, C., et al. (2019) FP189High Levels of Intestinal-Activated IgA+ B Lymphocytes Support the Pathogenic Role of Intestinal Mucosal Hyperresponsiveness in IgA Nephropathy Patients. Nephrology Dialysis Transplantation, 34. |
[10] | Ying, Y., Wang, L., Ma, S., Zhu, Y., Ye, S., Jiang, N., et al. (2024) An Enhanced Machine Learning Approach for Effective Prediction of IgA Nephropathy Patients with Severe Proteinuria Based on Clinical Data. Computers in Biology and Medicine, 173, Article 108341. https://doi.org/10.1016/j.compbiomed.2024.108341 |
[11] | 李玉玺, 孔玉科, 孙辉, 等. 肾病患者的血清IgA质量浓度与肠道菌群相关性研究[J]. 兰州大学学报: 医学版, 2021, 47(1): 1-7. |
[12] | Han, S., Shang, L., Lu, Y. and Wang, Y. (2022) Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies. Frontiers in Cellular and Infection Microbiology, 12, Article 904401. https://doi.org/10.3389/fcimb.2022.904401 |
[13] | 邹迪, 刘艳华, 张守琳, 等. 国医大师任继学治疗IgA肾病经验总结[J]. 时珍国医国药, 2022, 33(5): 1213-1215. |
[14] | 张璇, 姜睿斌, 张晓菊, 等. 基于NF-κB通路研究生地黄-玄参对糖尿病肾病大鼠肾脏微炎症状态的影响[J]. 国际中医中药杂志, 2022, 44(1): 49-55. |
[15] | 彭华东, 白发臣, 林研研, 等. 凉血散瘀方加减对肾虚血瘀型lgA肾病肾脏纤维化的影响分析[J]. 中外医学研究, 2020, 18(35): 37-39. |
[16] | 原所贤, 暴连英, 李一壮. 运用虫类药物治疗IgA肾病临证举隅[J]. 实用中医内科杂志, 2011, 25(8): 57-58. |
[17] | 张新阳. 利湿化瘀汤联合氯沙坦钾及雷公藤多苷治疗IgA肾病的临床效果[J]. 中外医学研究, 2019, 17(19): 34-36. |